Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Item No. 40344

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Nuclear receptor subfamily 4 group A member 3 (NR4A3) is a transcription factor and member of the NR4A orphan nuclear receptor family.1,2 It is composed of an N-terminal activation function-1 (AF-1) transactivation domain, a DNA-binding domain, a variable linker region, and a C-terminal domain comprising a ligand-binding domain and an AF-2 domain. NR4A3 is primarily expressed in the fetal brain and lungs and adult heart and skeletal muscle, with both splice variants showing similar expression patterns.3,4 It is involved in several biological processes, including apoptosis, differentiation, metabolism, inflammation, cardiac remodeling, and development, and its expression can be induced by several factors such as growth factors, cytokines, and stress.1,2 Knockout of Nr4a3 inhibits GM-CSF- and IL-4-induced differentiation of primary mouse monocytes into dendritic cells.5 Overexpression of NR4A3 reduces infarct size as a percentage of the area at risk in a mouse model of acute myocardial infarction.6 Fusion proteins of NR4A3 with Ewing sarcoma protein (EWS) or TAF15 are associated with extraskeletal myxoid chondrosarcoma.7
WARNING This product is not for human or veterinary use.
1. NR4A3: A key nuclear receptor in vascular biology, cardiovascular remodeling, and beyond. Int. J. Mol. Sci. 22(21), 11371 (2021).
2. Potential roles of Nr4a3-
3. Structure, mapping and expression of a human NOR-
4. Alternative splicing generates isoforms of human neuron-
5. The orphan nuclear receptor NR4A3 controls the differentiation of monocyte-
6. The protective role of NR4A3 in acute myocardial infarction by suppressing inflammatory responses via JAK2-
7. Extraskeletal myxoid chondrosarcoma: updated clinicopathological and molecular genetic characteristics. Pathol. Int. 55(8), 453-463 (2005).